OPTIAH Trademark

Trademark Overview


On Wednesday, June 14, 2017, a trademark application was filed for OPTIAH with the United States Patent and Trademark Office. The USPTO has given the OPTIAH trademark a serial number of 87488328. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 13, 2021. This trademark is owned by Eli Lilly and Company. The OPTIAH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use i...
optiah

General Information


Serial Number87488328
Word MarkOPTIAH
Filing DateWednesday, June 14, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 13, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 20, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, December 13, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 13, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 24, 2021EXTENSION 5 GRANTED
Thursday, April 22, 2021EXTENSION 5 FILED
Thursday, April 22, 2021TEAS EXTENSION RECEIVED
Saturday, October 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 30, 2020EXTENSION 4 GRANTED
Tuesday, October 27, 2020EXTENSION 4 FILED
Tuesday, October 27, 2020TEAS EXTENSION RECEIVED
Friday, April 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2020EXTENSION 3 GRANTED
Wednesday, April 8, 2020EXTENSION 3 FILED
Wednesday, April 8, 2020TEAS EXTENSION RECEIVED
Thursday, October 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2019EXTENSION 2 GRANTED
Thursday, October 10, 2019EXTENSION 2 FILED
Thursday, October 10, 2019TEAS EXTENSION RECEIVED
Thursday, April 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 10, 2019EXTENSION 1 GRANTED
Monday, April 8, 2019EXTENSION 1 FILED
Monday, April 8, 2019TEAS EXTENSION RECEIVED
Tuesday, November 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 24, 2018NEW NOA TO ISSUE
Tuesday, June 19, 2018NOTICE OF ALLOWANCE CANCELLED
Monday, September 24, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 31, 2018NOTICE OF REVIVAL - E-MAILED
Friday, August 31, 2018PETITION TO REVIVE-GRANTED
Friday, August 31, 2018TEAS PETITION TO REVIVE RECEIVED
Monday, July 23, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 23, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 19, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 14, 2017ASSIGNED TO EXAMINER
Tuesday, June 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 17, 2017NEW APPLICATION ENTERED IN TRAM